药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Omapatrilat
Cefonicid
Cefonicid may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Lumiracoxib
Lumiracoxib may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Olsalazine
Olsalazine may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Cefprozil
Cefprozil may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Cefapirin
Cefapirin may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Colistimethate
Colistimethate may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Cefditoren
Cefditoren may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Balsalazide
Balsalazide may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Oxaprozin
Oxaprozin may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Ceforanide
Ceforanide may decrease the excretion rate of Cefradine which could result in a higher serum level.
Omapatrilat
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Cefradine.
Omapatrilat
Incadronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefradine is combined with Incadronic acid.
Omapatrilat
Tiludronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefradine is combined with Tiludronic acid.
Omapatrilat
Etidronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefradine is combined with Etidronic acid.
Omapatrilat
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Cefradine.
Omapatrilat
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Cefradine.
Omapatrilat
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Hygromycin B.
Omapatrilat
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Dihydrostreptomycin.
Omapatrilat
Puromycin
The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Puromycin.
Omapatrilat
Neamine
The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Neamine.